UroGen Pharma Ltd. SEC filings URGN
UroGen Pharma Ltd. has 583 filings in SEC EDGAR's recent list, going back to Mar 4, 2016. Its latest annual report, Form ARS, was filed on May 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 20, 2026 | Aug 18, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Shareholder vote results
|
Jun 23, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Other events
|
Jun 2, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 2, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 27, 2025 | Aug 26, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 20, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 9, 2024 | Oct 7, 2024 |
| 8-K |
Current report
New debt
|
Sep 24, 2024 | Sep 23, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 13, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Other events
|
Aug 15, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 8, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 13, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 1, 2024 | Mar 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 7, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 17, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Material agreement
|
Jan 2, 2024 | Dec 28, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Sep 11, 2023 | Sep 7, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 27, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 22, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 9, 2022 | Nov 8, 2022 |
| 8-K |
Current report
New debt
|
Oct 21, 2022 | Oct 21, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 12, 2022 | Sep 8, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 13, 2022 | Jun 8, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 21, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 8, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Agreement ended, Results of operations
|
Nov 15, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Other events
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Other events
|
Sep 13, 2021 | Sep 13, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Jul 14, 2021 | Jul 14, 2021 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 8, 2021 | Jun 7, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 18, 2021 | Mar 18, 2021 |
| 8-K |
Current report
Other events
|
Jan 13, 2021 | Jan 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Other events
|
Dec 3, 2020 | Dec 3, 2020 |
| 8-K |
Current report
Other events
|
Nov 17, 2020 | Nov 17, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2020 | Nov 9, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2020 | Sep 3, 2020 |
| 8-K |
Current report
Other events
|
Aug 27, 2020 | Aug 27, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2020 | Aug 10, 2020 |
| 8-K |
Current report
Auditor change, Officer or director change, Shareholder vote results
|
Jun 10, 2020 | Jun 8, 2020 |
| 8-K |
Current report
Other events
|
May 15, 2020 | May 15, 2020 |
| 8-K |
Current report
Other events
|
Apr 16, 2020 | Apr 15, 2020 |
| 8-K |
Current report
Officer or director change
|
Mar 23, 2020 | Mar 20, 2020 |
| 8-K |
Current report
Other events
|
Dec 20, 2019 | Dec 20, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 22, 2019 | Nov 22, 2019 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2019 | Nov 12, 2019 |
| 8-K |
Current report
Material agreement
|
Nov 12, 2019 | Nov 8, 2019 |
| 8-K |
Current report
Material agreement
|
Nov 8, 2019 | Nov 4, 2019 |
| 8-K |
Current report
Other events
|
Sep 24, 2019 | Sep 24, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2019 | Aug 9, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2019 | Jun 3, 2019 |
| 8-K |
Current report
Other events
|
May 28, 2019 | May 21, 2019 |
| 8-K |
Current report
Results of operations
|
May 9, 2019 | May 9, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2019 | Feb 28, 2019 |
| 8-K |
Current report
Other events
|
Jan 25, 2019 | Jan 23, 2019 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Jan 22, 2019 | Jan 22, 2019 |
| 8-K |
Current report
Other events
|
Jan 9, 2019 | Jan 8, 2019 |
| 8-K |
Current report
Officer or director change
|
Jan 4, 2019 | Jan 3, 2019 |
| 6-K | Current report (foreign issuer) | Nov 13, 2018 | Sep 30, 2018 |
| 6-K | Current report (foreign issuer) | Oct 31, 2018 | Oct 31, 2018 |
| 6-K | Current report (foreign issuer) | Oct 1, 2018 | Sep 28, 2018 |
| 6-K | Current report (foreign issuer) | Sep 21, 2018 | Sep 20, 2018 |
| 6-K | Current report (foreign issuer) | Sep 18, 2018 | Sep 18, 2018 |
| 6-K | Current report (foreign issuer) | Aug 30, 2018 | Aug 30, 2018 |
| 6-K | Current report (foreign issuer) | Aug 14, 2018 | Aug 14, 2018 |
| 6-K | Current report (foreign issuer) | Aug 8, 2018 | Aug 8, 2018 |
| 6-K | Current report (foreign issuer) | Jul 13, 2018 | Jul 11, 2018 |
| 6-K | Current report (foreign issuer) | Jun 6, 2018 | Jun 6, 2018 |
| 6-K | Current report (foreign issuer) | Jun 6, 2018 | Jun 6, 2018 |
| 6-K | Current report (foreign issuer) | May 15, 2018 | May 15, 2018 |
| 6-K | Current report (foreign issuer) | Apr 25, 2018 | Apr 25, 2018 |
| 6-K | Current report (foreign issuer) | Apr 4, 2018 | Apr 4, 2018 |
| 6-K | Current report (foreign issuer) | Mar 16, 2018 | Mar 15, 2018 |
| 6-K | Current report (foreign issuer) | Feb 20, 2018 | Feb 20, 2018 |
| 6-K | Current report (foreign issuer) | Feb 14, 2018 | Feb 14, 2018 |
| 6-K | Current report (foreign issuer) | Jan 11, 2018 | Jan 11, 2018 |
| 6-K | Current report (foreign issuer) | Jan 8, 2018 | Jan 8, 2018 |
| 6-K | Current report (foreign issuer) | Dec 14, 2017 | Dec 14, 2017 |
| 6-K | Current report (foreign issuer) | Nov 14, 2017 | Nov 14, 2017 |
| 6-K | Current report (foreign issuer) | Nov 7, 2017 | Nov 7, 2017 |
| 6-K | Current report (foreign issuer) | Nov 2, 2017 | Nov 2, 2017 |
| 6-K | Current report (foreign issuer) | Aug 29, 2017 | Aug 29, 2017 |
| 6-K | Current report (foreign issuer) | Aug 14, 2017 | Aug 14, 2017 |
| 6-K | Current report (foreign issuer) | Jul 19, 2017 | Jul 19, 2017 |
| 6-K | Current report (foreign issuer) | May 18, 2017 | May 18, 2017 |
Showing 112 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- URGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Ra'Anana, Israel
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1668243
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.